MEDSCI (02415) released its interim results, reporting a net profit of 10.638 million yuan, a year-on-year decrease of 19.7%.
Meis Health (02415) announced its mid-term results for 2026, reporting a revenue of 117 million yuan (RMB, the same below), a year-on-year decrease of 6.2%; net profit of 10.638 million yuan, a year-on-year decrease of 19.7%; and basic earnings per share of 1.94 cents.
MEDSCI (02415) announced its mid-year results for 2026, reporting revenues of 117 million yuan (RMB, the same below), a year-on-year decrease of 6.2%; net profit of 10.638 million yuan, a year-on-year decrease of 19.7%; and basic earnings per share of 1.94 cents.
The announcement stated that the decrease in revenue was primarily driven by a reduction in demand for simple language clinical research due to the widespread adoption of AI technology.
Related Articles
YIK WO INTL (08659) announced its interim results, reporting a loss of 8.599 million yuan during the period, a reversal from profit to loss compared to the same period last year.
SUPERROBOTICS (08176) announced its interim results, reporting a loss attributable to shareholders of HKD 3.4 million, a year-on-year decrease of 41.1%.
METASURFACE (08637) released its interim results, with a net profit attributable to shareholders of SGD 3.705 million, a decrease of 57.69% compared to the same period last year.
YIK WO INTL (08659) announced its interim results, reporting a loss of 8.599 million yuan during the period, a reversal from profit to loss compared to the same period last year.
SUPERROBOTICS (08176) announced its interim results, reporting a loss attributable to shareholders of HKD 3.4 million, a year-on-year decrease of 41.1%.
METASURFACE (08637) released its interim results, with a net profit attributable to shareholders of SGD 3.705 million, a decrease of 57.69% compared to the same period last year.
RECOMMEND
